Amit D. Gujar
Affiliations: | Washington University School of Medicine, St. Louis, MO, United States |
Area:
NeurooncologyGoogle:
"Amit Gujar"Mean distance: 17.05 (cluster 32) | S | N | B | C | P |
Cross-listing: Neuropathology Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mao DD, Cleary RT, Gujar A, et al. (2022) CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells. Plos One. 17: e0270251 |
Mahlokozera T, Patel B, Chen H, et al. (2021) Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nature Communications. 12: 6321 |
Gujar AD, Mao DD, Finlay JB, et al. (2018) Establishing Primary Human Glioblastoma Adherent Cultures from Operative Specimens. Methods in Molecular Biology (Clifton, N.J.). 1741: 53-62 |
Huang J, Campian JL, Gujar AD, et al. (2018) Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology |
Mahlokozera T, Taiwo R, Mao D, et al. (2018) STEM-07. NON-CANONICAL REGULATION OF SOX2 BY THE TRIM26 E3 UBIQUITIN LIGASE IN GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 20: vi245-vi245 |
Huang J, Campian J, Gujar A, et al. (2017) Actr-21. Updated Results Of A Phase I Dose-Escalation, Dose-Expansion Study Of Disulfiram And Adjuvant Temozolomide For Newly Diagnosed Glioblastoma Neuro-Oncology. 19 |
Gujar AD, Le S, Mao DD, et al. (2016) An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America |
Gujar AD, Yano H, Kim AH. (2016) The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma. Molecular & Cellular Oncology. 3: e1075644 |
Huang J, Campian JL, Gujar AD, et al. (2016) A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. Journal of Neuro-Oncology |
Kang SK, Murphy RK, Hwang SW, et al. (2016) Bioresorbable silicon electronic sensors for the brain. Nature |